| Active immunotherapy for non-small-cell lung cancer: moving toward a reality CA Perez, ES Santos, LE Raez Expert Review of Anticancer Therapy 11 (10), 1599-1605, 2011 | 109 | 2011 |
| Overcoming the resistance to crizotinib in patients with non-small cell lung cancer harboring EML4/ALK translocation CA Perez, M Velez, LE Raez, ES Santos Lung cancer 84 (2), 110-115, 2014 | 64 | 2014 |
| Novel molecular targeted therapies for refractory thyroid cancer CA Perez, ES Santos, BA Arango, LE Raez, EEW Cohen Head & neck 34 (5), 736-745, 2012 | 47 | 2012 |
| Primary mediastinal large B-cell lymphoma during pregnancy CA Perez, J Amin, LM Aguina, M Cioffi-Lavina, ES Santos Case reports in hematology 2012, 2012 | 44 | 2012 |
| Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck CA Perez, H Song, LE Raez, M Agulnik, TA Grushko, A Dekker, K Stenson, ... Oral oncology 48 (9), 887-892, 2012 | 42 | 2012 |
| Distribution of cervical lymph node metastases from squamous cell carcinoma of the oropharynx in the era of risk stratification using human papillomavirus and smoking status MJ Amsbaugh, M Yusuf, E Cash, C Silverman, E Wilson, J Bumpous, ... International Journal of Radiation Oncology* Biology* Physics 96 (2), 349-353, 2016 | 38 | 2016 |
| Targeting the Met pathway in lung cancer A Belalcazar, D Azaña, CA Perez, LE Raez, ES Santos Expert review of anticancer therapy 12 (4), 519-528, 2012 | 37 | 2012 |
| Ethical surgical triage of patients with head and neck cancer during the COVID‐19 pandemic FJ Civantos, JM Leibowitz, DJ Arnold, VC Stubbs, JH Gross, GR Thomas, ... Head & neck 42 (7), 1423-1447, 2020 | 28 | 2020 |
| Management of immunotherapy toxicities in older adults S Bhandari, AS Gill, CA Perez, D Jain Seminars in Oncology 45 (4), 226-231, 2018 | 25 | 2018 |
| Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens TS Finnegan, NH Bhatt, JN Shaughnessy, C Perez, R Redman, ... J Community Support Oncol 14 (1), 29-36, 2016 | 25 | 2016 |
| PF-06939999, a potent and selective PRMT5 inhibitor, in patients with advanced or metastatic solid tumors: A phase 1 dose escalation study. J Rodon Ahnert, CA Perez, KM Wong, ML Maitland, F Tsai, J Berlin, ... Journal of Clinical Oncology 39 (15_suppl), 3019-3019, 2021 | 24 | 2021 |
| Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond Z Kanaan, GH Kloecker, A Paintal, CA Perez OncoTargets and therapy, 885-892, 2015 | 23 | 2015 |
| Nasopharyngeal carcinoma: alternative treatment options after disease progression BA Arango, AB Castrellon, CA Perez, LE Raez, ES Santos Expert Review of Anticancer Therapy 10 (3), 377-386, 2010 | 23 | 2010 |
| Radioactive iodine-refractory differentiated thyroid cancer in the elderly R Gosain, JS Alexander, A Gill, C Perez Current Oncology Reports 20, 1-6, 2018 | 21 | 2018 |
| Neck dissection for unknown cancer of the head and neck in the era of chemoradiation MJ Amsbaugh, M Yusuf, J Gaskins, C Silverman, K Potts, J Bumpous, ... American Journal of Otolaryngology 38 (5), 588-592, 2017 | 21 | 2017 |
| Systemic lupus erythematosus presenting as thrombotic thrombocytopenia purpura: how close is close enough? CA Perez, N Abdo, A Shrestha, ES Santos Case Reports in Medicine 2011, 2011 | 20 | 2011 |
| EGF receptor in lung cancer: a successful story of targeted therapy G Domingo, CA Perez, M Velez, J Cudris, LE Raez, ES Santos Expert review of anticancer therapy 10 (10), 1577-1587, 2010 | 20 | 2010 |
| 919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch … R Ferrarotto, LJ Wirth, J Muzaffar, CP Rodriguez, B Xia, CA Perez, ... Annals of Oncology 31, S663, 2020 | 18 | 2020 |
| Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer M Velez, BA Arango, CA Perez, ES Santos Clinical Medicine Insights: Oncology 6, CMO. S6248, 2012 | 18 | 2012 |
| High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck CA Perez, X Wu, MJ Amsbaugh, R Gosain, WM Claudino, M Yusuf, ... Oral Oncology 67, 24-28, 2017 | 17 | 2017 |
Liz Cash, PhDHealth Psychologist, Associate Professor, Dept of Otolayngology-HNS & Communicative DisordersVerified email at louisville.edu
